ResultsNDTV Profit
Nirmal Bang raises Jubilant Pharmova target to Rs 1266
Positive+67
GreyOak summary
Jubilant Pharmova reported 20.5% YoY revenue growth in Q2.
What it affects
- Jubilant PharmovaJUBLPHARMAPositive +67
Revenue grew 20.5%; broker raises target.Rolling sentiment Neutral -12
Source
Read the original at NDTV ProfitMore Jubilant Pharmova news
- Earnings Central: From Tata Motors, Eicher and Manipal Health to Jubilant Pharmova, the hits and missesCNBC-TV18 · Results ·
- Jubilant Pharmova Q2 net profit falls 74.1%CNBC-TV18 · Results ·
- Coca-Cola IPO docs show veto power over JubilantMoneycontrol · IPO & listing ·